ABIO / ARCA biopharma, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

ARCA biopharma, Inc.
US ˙ NasdaqCM ˙ US00211Y5069
DIESES SYMBOL IST NICHT MEHR AKTIV

Insider-Aktien17.989.561 shares
Insider-Stimmungswert

Der Insider-Stimmungswert ermittelt die Unternehmen, die von Unternehmensinsidern gekauft werden.

Es ist das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Insiderakkumulation identifiziert. Das Scoring-Modell verwendet eine Kombination aus der Nettozahl der Insiderkäufe der letzten 90 Tage, der Gesamtzahl der gekauften Aktien als Prozentsatz des Streubesitzes und der Gesamtzahl der von Insidern gehaltenen Aktien. Die Zahl reicht von 0 bis 100, wobei höhere Zahlen ein höheres Maß an Insiderkäufen anzeigen als bei anderen Unternehmen und 50 den Durchschnitt darstellt.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Top-Optionen der Insider an, die eine Liste der Unternehmen mit der höchsten Insiderakkumulation enthalten.

Führungskräfte-Stimmungswert

Der Führungskräfte-Stimmungswert findet Unternehmen, die von Führungskräften des Unternehmens gekauft werden.

Per Definition sind Führungskräfte des Unternehmens Insider, aber im Gegensatz zu anderen Insidern (10%ige Aktionäre und Vorstandsmitglieder) arbeiten Führungskräfte täglich für das Unternehmen und verwenden beim Handel ihr eigenes Geld. (10%ige Aktionäre und Vorstandsmitglieder sind oft Fondsmanager, die das Geld anderer Leute verwalten.) Daher sind Insider-Geschäfte, die von Führungskräften getätigt werden, viel bedeutender und sollten entsprechend behandelt werden.

Wie der Insider-Stimmungswert ist auch der Führungskräfte-Stimmungswert das Ergebnis eines ausgeklügelten quantitativen Multifaktormodells, das die Unternehmen mit der höchsten Führungskräftekonzentration identifiziert.

Aktualisierungshäufigkeit: Täglich

Sehen Sie sich die Insiders Top-Auswahl an, die eine Liste der Unternehmen mit der höchsten Insider-Stimmung enthalten.

Wichtige Insider-Kennzahlen

Diese Karte zeigt, wie das Unternehmen bei verschiedenen Insider-Kennzahlen abschneidet. Der Perzentil-Rang zeigt, wie dieses Unternehmen im Vergleich zu anderen Unternehmen auf den US-Märkten abschneidet. Höhere Ränge deuten auf eine bessere Situation hin.

Es ist beispielsweise allgemein anerkannt, dass Insiderkäufe ein positiver Indikator sind, so dass Unternehmen mit mehr Insiderkäufen besser abschneiden würden als Unternehmen mit weniger Insiderkäufen (oder sogar Insiderverkäufen).

Nettoanzahl der Insider, die kaufen (Rang)

N/A

Die Nettoanzahl der Insiderkäufe ist die Gesamtzahl der Insiderkäufe abzüglich der Gesamtzahl der Insiderverkäufe in den letzten 90 Tagen. Der Perzentilrang wird hier angezeigt (Bereich von 0 bis 100%).

Prozent des Streubesitzes von Insidern gekauft (Rang)

N/A

Prozent des von Insidern gekauften Streubesitzes ist die Gesamtzahl der von Insidern gekauften Aktien abzüglich der Gesamtzahl der von Insidern in den letzten 90 Tagen verkauften Aktien, geteilt durch den gesamten Streubesitz und multipliziert mit 100.

Diagramm zum Insiderhandel

ARCA biopharma, Inc. Insider-Trades sind in der folgenden Grafik dargestellt. Insider sind leitende Angestellte, Direktoren oder bedeutende Investoren in einem Unternehmen. Im Allgemeinen ist es für Insider illegal, auf der Grundlage von wesentlichen, nicht-öffentlichen Informationen mit Aktien ihrer Unternehmen zu handeln. Das bedeutet nicht, dass es für sie illegal ist, irgendwelche Geschäfte in ihren eigenen Unternehmen zu tätigen. Sie müssen jedoch alle Geschäfte der SEC über ein Formular 4 melden.

Kennzahlen zu Insiderlisten und Rentabilität

Diese Tabelle zeigt die Liste der bekannten Insider und wird automatisch aus den bei der SEC eingereichten Unterlagen erstellt. Zusätzlich zu den Namen, dem letzten Titel und der Bezeichnung als Direktor, leitender Angestellter oder 10%-iger Anteilseigner geben wir die zuletzt veröffentlichten Bestände an. Zusätzlich stellen wir, wenn möglich, die historische Handelsperformance für den Insider zur Verfügung. Die historische Handelsperformance ist ein gewichteter Durchschnitt der Performance tatsächlicher offener Kauftransaktionen, die von dem Insider getätigt wurden. Weitere Informationen zur Berechnung dieses Wertes finden Sie in diesem YouTube-Webinar.

See our leaderboard of most profitable insider traders.

Insider Durchschnittlicher Gewinn (%) Aktien
in Besitz
Split
Angepasst

Report errors via our new Insider Auditing Tool

Erfolgsbilanz der Insiderkäufe - Kurzfristige Gewinnanalyse

In diesem Abschnitt analysieren wir die Rentabilität jedes ungeplanten Insiderkaufs, der auf dem freien Markt in ABIO / ARCA biopharma, Inc. getätigt wurde. Diese Analyse hilft zu verstehen, ob der Insider beständig abnormale Renditen erzielt und es sich lohnt, ihm zu folgen. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Käufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Max
Preis bei
Max
Max
Gewinn ($)
Max Rendite (%)
2025-02-14 Venrock Healthcare Capital Partners III, L.P. 88.794 11,4400 88.794 11,4400 1.015.803 0
2025-02-13 Venrock Healthcare Capital Partners III, L.P. 14.950 11,6300 14.950 11,6300 173.868
2025-02-12 Venrock Healthcare Capital Partners III, L.P. 8.971 11,8600 8.971 11,8600 106.396
2025-02-11 Venrock Healthcare Capital Partners III, L.P. 9.593 10,9500 9.593 10,9500 105.043
2025-02-10 Venrock Healthcare Capital Partners III, L.P. 574 10,9000 574 10,9000 6.257
2024-08-16 JANUS HENDERSON GROUP PLC 5.390 2,9300 449 35,1600 15.793
2024-08-16 JANUS HENDERSON GROUP PLC 428 2,9768 36 35,7216 1.274
2024-07-25 JANUS HENDERSON GROUP PLC 30.227 3,0533 2.519 36,6396 92.292
2024-07-24 JANUS HENDERSON GROUP PLC 165.000 3,2000 13.750 38,4000 528.000

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

ABIO / ARCA biopharma, Inc. Insider Trades
Erfolgsbilanz von Insiderverkäufen - Kurzfristige Verlustanalyse

In diesem Abschnitt analysieren wir die kurzfristige Verlustvermeidung jedes ungeplanten Insider-Verkaufs auf dem freien Markt in ABIO / ARCA biopharma, Inc.. Ein konsistentes Muster der Verlustvermeidung kann darauf hindeuten, dass zukünftige Verkaufstransaktionen Kursrückgänge vorhersagen können. Diese Analyse bezieht sich auf ein Jahr nach jedem Handel, und die Ergebnisse sind theoretisch .

Die folgende Tabelle zeigt die jüngsten Verkäufe am offenen Markt, die nicht Teil eines automatischen Handelsplans waren.

Handelsdatum Insider Gemeldete
Aktien
Gemeldeter
Preis
Angepasste
Aktien
Angepasster
Preis
Kostenbasis Tage bis
Min
Preis bei
Min
Max Verlust
Vermieden($)
Max Verlust
Vermieden(%)
2026-03-16 Sandler Laura Lee 600 41,3000 600 41,3000 24.780 0
2026-03-16 Agarwal Arjun 395 41,3000 395 41,3000 16.314
2026-03-16 Quinlan Paul T 733 41,3000 733 41,3000 30.273
2026-03-16 Goncalves Joana 641 41,3000 641 41,3000 26.473
2026-03-16 Klein Lawrence Otto 1.729 41,3000 1.729 41,3000 71.408
2018-02-27 VENROCK HEALTHCARE CAPITAL PARTNERS LP 41.331 0,5300 2.755 7,9500 21.905
2018-02-26 Growth Equity Opportunities IV, LLC 1.460.209 0,5008 97.347 7,5120 731.273

Bereinigter Preis ist der splitbereinigte Preis. Bereinigte Aktien sind die um den Split bereinigten Aktien.

ABIO / ARCA biopharma, Inc. Insider Trades
Transaktionshistorie

Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen. Transaktionen, die im Rahmen eines automatischen Handelsplans 10b5-1 gemeldet werden, sind in der Spalte 10b-5 mit einem X gekennzeichnet.

Datei
Datum
Handel
Datum
Form Insider Ticker Wertpapier-Titel Code 10b5-1 Direkt Ausführung
Preis
Einheit
Preis
Eimheiten
Verändert
Wert
Geändert (1K)
Verbleibende
Optionen
Verbleibende
Aktien
2026-05-22 2026-05-21 4 Dambkowski Carl ORKA Common Stock S - Sale D 59,9669 -13.235 -794 73.743
2026-05-22 2026-05-21 4 Dambkowski Carl ORKA Common Stock S - Sale D 59,1036 -53.447 -3.159 86.978
2026-05-22 2026-05-21 4 Dambkowski Carl ORKA Common Stock S - Sale D 58,4267 -38.318 -2.239 140.425
2026-05-22 2026-05-21 4 Dambkowski Carl ORKA Common Stock M - Exercise D 11,7700 11.667 137 178.743
2026-05-22 2026-05-21 4 Dambkowski Carl ORKA Common Stock M - Exercise D 7,8000 11.904 93 167.076
2026-05-22 2026-05-21 4 Dambkowski Carl ORKA Common Stock M - Exercise D 6,8400 38.689 265 155.172
2026-05-18 2026-05-18 4 Agarwal Arjun ORKA Common Stock S - Sale D 61,1606 -700 -43 16.406
2026-05-18 2026-05-18 4 Agarwal Arjun ORKA Common Stock S - Sale D 60,3364 -800 -48 17.106
2026-05-18 2026-05-18 4 Agarwal Arjun ORKA Common Stock S - Sale D 59,1869 -4.600 -272 17.906
2026-05-18 2026-05-18 4 Agarwal Arjun ORKA Common Stock S - Sale D 58,3449 -4.190 -244 22.506
2026-05-18 2026-05-18 4 Agarwal Arjun ORKA Common Stock M - Exercise D 34,3900 5.833 201 26.696
2026-05-18 2026-05-18 4 Agarwal Arjun ORKA Common Stock M - Exercise D 12,5000 2.000 25 20.863
2026-05-15 2026-05-15 4 Goncalves Joana ORKA Common Stock S - Sale D 63,5200 -100 -6 33.377
2026-05-15 2026-05-15 4 Goncalves Joana ORKA Common Stock S - Sale D 62,4230 -2.100 -131 33.477
2026-05-15 2026-05-15 4 Goncalves Joana ORKA Common Stock S - Sale D 61,5614 -4.800 -295 35.577
2026-05-15 2026-05-15 4 Goncalves Joana ORKA Common Stock M - Exercise D 7,8000 3.500 27 40.377
2026-05-15 2026-05-15 4 Goncalves Joana ORKA Common Stock M - Exercise D 6,8400 3.500 24 36.877
2026-05-01 2026-05-01 4 Sandler Laura Lee ORKA Common Stock S - Sale D 68,4800 -100 -7 236.984
2026-05-01 2026-05-01 4 Sandler Laura Lee ORKA Common Stock S - Sale D 67,1550 -200 -13 237.084
2026-05-01 2026-05-01 4 Sandler Laura Lee ORKA Common Stock S - Sale D 66,0550 -400 -26 237.284
2026-05-01 2026-05-01 4 Sandler Laura Lee ORKA Common Stock S - Sale D 65,1000 -300 -20 237.684
2026-05-01 2026-05-01 4 Sandler Laura Lee ORKA Common Stock S - Sale D 64,1488 -1.800 -115 237.984
2026-05-01 2026-05-01 4 Sandler Laura Lee ORKA Common Stock S - Sale D 62,5843 -2.200 -138 239.784
2026-05-01 2026-05-01 4 Sandler Laura Lee ORKA Common Stock M - Exercise D 7,8000 5.000 39 241.984
2026-04-15 2026-04-15 4 Goncalves Joana ORKA Common Stock S - Sale D 67,3840 -500 -34 33.377
2026-04-15 2026-04-15 4 Goncalves Joana ORKA Common Stock S - Sale D 66,5643 -2.273 -151 33.877
2026-04-15 2026-04-15 4 Goncalves Joana ORKA Common Stock S - Sale D 65,7291 -4.227 -278 36.150
2026-04-15 2026-04-15 4 Goncalves Joana ORKA Common Stock M - Exercise D 7,8000 3.500 27 40.377
2026-04-15 2026-04-15 4 Goncalves Joana ORKA Common Stock M - Exercise D 6,8400 3.500 24 36.877
2026-03-17 2026-03-16 4 Klein Lawrence Otto ORKA Common Stock S - Sale D 41,3000 -1.729 -71 927.309
2026-03-17 2026-03-16 4 Agarwal Arjun ORKA Common Stock S - Sale D 41,3000 -395 -16 18.863
2026-03-17 2026-03-16 4 Sandler Laura Lee ORKA Common Stock S - Sale D 41,3000 -600 -25 236.984
2026-03-17 2026-03-16 4 Goncalves Joana ORKA Common Stock S - Sale D 41,3000 -641 -26 33.377
2026-03-17 2026-03-16 4 Goncalves Joana ORKA Common Stock S - Sale D 41,9361 -1.177 -49 34.018
2026-03-17 2026-03-16 4 Goncalves Joana ORKA Common Stock S - Sale D 41,2022 -2.902 -120 35.195
2026-03-17 2026-03-16 4 Goncalves Joana ORKA Common Stock S - Sale D 40,1091 -2.921 -117 38.097
2026-03-17 2026-03-16 4 Goncalves Joana ORKA Common Stock M - Exercise D 7,8000 3.500 27 41.018
2026-03-17 2026-03-16 4 Goncalves Joana ORKA Common Stock M - Exercise D 6,8400 3.500 24 37.518
2026-03-17 2026-03-16 4 Quinlan Paul T ORKA Common Stock S - Sale D 41,3000 -733 -30 31.767
2026-03-02 2026-03-02 4 Sandler Laura Lee ORKA Common Stock S - Sale D 33,8077 -2.675 -90 237.584
2026-03-02 2026-03-02 4 Sandler Laura Lee ORKA Common Stock S - Sale D 33,2843 -2.325 -77 240.259
2026-03-02 2026-03-02 4 Sandler Laura Lee ORKA Common Stock M - Exercise D 7,8000 5.000 39 242.584
2026-02-17 2026-02-17 4 Goncalves Joana ORKA Common Stock S - Sale D 32,7842 -936 -31 34.018
2026-02-17 2026-02-17 4 Goncalves Joana ORKA Common Stock S - Sale D 32,3009 -6.064 -196 34.954
2026-02-17 2026-02-17 4 Goncalves Joana ORKA Common Stock M - Exercise D 7,8000 3.500 27 41.018
2026-02-17 2026-02-17 4 Goncalves Joana ORKA Common Stock M - Exercise D 6,8400 3.500 24 37.518
2026-01-23 2026-01-23 4 Goncalves Joana ORKA Common Stock A - Award D 32.500 34.018
2026-01-23 2026-01-23 4 Sandler Laura Lee ORKA Common Stock A - Award D 32.500 237.584
2026-01-23 2026-01-23 4 Agarwal Arjun ORKA Common Stock A - Award D 17.500 19.258
2026-01-23 2026-01-23 4 Klein Lawrence Otto ORKA Common Stock A - Award D 76.700 929.038
2026-01-23 2026-01-23 4 Quinlan Paul T ORKA Common Stock A - Award D 32.500 32.500
2026-01-23 2026-01-23 4 Dambkowski Carl ORKA Common Stock J - Other D 116.483 116.483
2026-01-16 2026-01-15 4 Goncalves Joana ORKA Common Stock S - Sale D 32,2370 -2.619 -84 1.518
2026-01-16 2026-01-15 4 Goncalves Joana ORKA Common Stock S - Sale D 31,5626 -4.381 -138 4.137
2026-01-16 2026-01-15 4 Goncalves Joana ORKA Common Stock M - Exercise D 7,8000 3.500 27 8.518
2026-01-16 2026-01-15 4 Goncalves Joana ORKA Common Stock M - Exercise D 6,8400 3.500 24 5.018
2026-01-02 2026-01-02 4 Sandler Laura Lee ORKA Common Stock S - Sale D 29,7536 -1.108 -33 205.084
2026-01-02 2026-01-02 4 Sandler Laura Lee ORKA Common Stock S - Sale D 29,0814 -3.144 -91 206.192
2026-01-02 2026-01-02 4 Sandler Laura Lee ORKA Common Stock S - Sale D 28,1660 -8.748 -246 209.336
2026-01-02 2026-01-02 4 Sandler Laura Lee ORKA Common Stock M - Exercise D 7,8000 5.000 39 218.084
2025-12-19 2025-12-19 4 Goncalves Joana ORKA Common Stock S - Sale D 31,5790 -3.080 -97 1.518
2025-12-19 2025-12-19 4 Goncalves Joana ORKA Common Stock S - Sale D 30,7011 -1.492 -46 4.598
2025-12-19 2025-12-19 4 Goncalves Joana ORKA Common Stock S - Sale D 29,6220 -1.787 -53 6.090
2025-12-19 2025-12-19 4 Goncalves Joana ORKA Common Stock S - Sale D 28,5322 -641 -18 7.877
2025-12-19 2025-12-19 4 Goncalves Joana ORKA Common Stock M - Exercise D 7,8000 3.500 27 8.518
2025-12-19 2025-12-19 4 Goncalves Joana ORKA Common Stock M - Exercise D 6,8400 3.500 24 5.018
2025-09-19 2025-09-17 4 Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. ORKA Common Stock A - Award I 15,0000 333.340 5.000 1.131.954
2025-07-01 3 Sandler Laura Lee ORKA Common Stock D 213.084
2025-02-27 3 Venrock Healthcare Capital Partners III, L.P. By Funds ORKA Common Stock I 4.025.546
2025-02-27 2025-02-14 4 Venrock Healthcare Capital Partners III, L.P. By Funds ORKA Common Stock P - Purchase I 11,4400 88.794 1.016 4.148.428
2025-02-27 2025-02-13 4 Venrock Healthcare Capital Partners III, L.P. By Funds ORKA Common Stock P - Purchase I 11,6300 14.950 174 4.059.634
2025-02-27 2025-02-12 4 Venrock Healthcare Capital Partners III, L.P. By Funds ORKA Common Stock P - Purchase I 11,8600 8.971 106 4.044.684
2025-02-27 2025-02-11 4 Venrock Healthcare Capital Partners III, L.P. By Funds ORKA Common Stock P - Purchase I 10,9500 9.593 105 4.035.713
2025-02-27 2025-02-10 4 Venrock Healthcare Capital Partners III, L.P. By Funds ORKA Common Stock P - Purchase I 10,9000 574 6 4.026.120
2024-11-21 2024-11-19 4 Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. ORKA Common Stock M - Exercise I 160.000 798.614
2024-09-13 2024-09-11 4 Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. ORKA Common Stock A - Award I 23,0000 275.000 6.325 638.614
2024-09-06 3 Fairmount Funds Management LLC By Fairmount Healthcare Co-Invest III L.P. ORKA Common Stock I 2.573.308
2024-09-06 3 Fairmount Funds Management LLC By Fairmount Healthcare Fund II L.P. ORKA Common Stock I 363.614
2024-09-06 3 Turtle Cameron By Turtle Family Trust ORKA Common Stock I 85.233
2024-09-06 3 Klein Lawrence Otto ORKA Common Stock D 852.338
2024-08-20 2024-08-16 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 2,9768 428 1 2.117.213
2024-08-20 2024-08-16 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 2,9300 5.390 16 2.116.785
2024-07-26 2024-07-25 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,0533 30.227 92 2.111.395
2024-07-26 2024-07-24 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,1573 7.056 22 2.081.168
2024-07-26 2024-07-24 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,1795 17.800 57 2.074.112
2024-07-26 2024-07-24 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,2000 165.000 528 2.056.312
2024-07-12 2024-07-11 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,4516 94.537 326 1.891.312
2024-07-12 2024-07-10 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,4632 21.963 76 1.796.775
2024-07-12 2024-07-10 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,4647 33.500 116 1.774.812
2024-07-12 2024-07-09 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,4339 16.917 58 1.741.312
2024-07-12 2024-07-08 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,5350 17.600 62 1.724.395
2024-07-12 2024-07-08 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,4114 29.892 102 1.706.795
2024-07-12 2024-07-05 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,4100 5.000 17 1.676.903
2024-07-12 2024-07-05 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,4303 23.326 80 1.671.903
2024-07-12 2024-07-03 4 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock P - Purchase I 3,5507 166.042 590 1.648.577
2024-07-12 3 JANUS HENDERSON GROUP PLC By Fund ABIO Common Stock I 1.482.535
2022-12-19 2022-12-16 4 Funicular Funds, LP ABIO Common Stock X - Other D 2,5000 1.420.000 3.550 4.000.452
2022-12-09 2022-12-08 4 Dekker C. Jeffrey ABIO Common Stock A - Award D 40.000 40.000
2022-12-09 2022-12-08 4 Keuer Thomas A ABIO Common Stock A - Award D 40.000 40.730
2022-07-08 2022-07-01 4 Funicular Funds, LP ABIO Common Stock J - Other D 2.580.452 2.580.452
2022-07-08 2022-07-01 4 Funicular Funds, LP By the Funicular Fund, LP ABIO Common Stock J - Other I -2.580.452 2.580.452
2022-07-08 3 Funicular Funds, LP By Funicular Funds, LP ABIO Common Stock I 2.580.452
2022-06-21 3 Ma-Weaver Jacob By the Funicular Fund ABIO Common Stock I 2.580.452
2022-05-25 2022-05-25 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3244 64.851 151 2.580.452
2022-05-25 2022-05-24 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2851 18.110 41 2.515.601
2022-05-25 2022-05-23 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2950 2.301 5 2.497.491
2022-05-20 2022-05-19 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2500 1 0 2.495.190
2022-05-20 2022-05-18 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3046 13.072 30 2.495.189
2022-05-16 2022-05-16 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2987 42.914 99 2.482.117
2022-05-16 2022-05-13 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2942 14.000 32 2.439.203
2022-05-16 2022-05-12 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2698 27.922 63 2.425.203
2022-05-11 2022-05-11 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2850 24.596 56 2.397.281
2022-05-11 2022-05-10 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2845 20.979 48 2.372.685
2022-05-09 2022-05-09 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2698 49.221 112 2.351.706
2022-05-09 2022-05-06 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2827 57.998 132 2.302.485
2022-05-09 2022-05-05 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2747 16.903 38 2.244.487
2022-05-02 2022-05-02 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3150 1.259 3 2.227.584
2022-05-02 2022-04-29 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3004 8.974 21 2.226.325
2022-05-02 2022-04-28 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3169 23.381 54 2.217.351
2022-04-27 2022-04-25 4 Funicular Fund, LP ABIO Put Option (obligation to buy) S - Sale D 2,50 64,0000 -7.500 -480 14.500
2022-04-27 2022-04-25 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2913 13.751 32 2.193.970
2022-04-20 2022-04-19 4 Funicular Fund, LP ABIO Put Option (obligation to buy) S - Sale D 2,50 64,0000 -7.000 -448 7.000
2022-04-20 2022-04-18 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3117 9.119 21 2.180.219
2022-04-14 2022-04-14 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3289 17.410 41 2.171.100
2022-04-12 2022-04-12 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3214 69.398 161 2.153.690
2022-04-12 2022-04-11 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3150 4.655 11 2.084.292
2022-04-12 2022-04-08 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3109 30.660 71 2.079.637
2022-04-07 2022-04-07 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3208 27.450 64 2.048.977
2022-04-07 2022-04-06 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2981 26.806 62 2.021.527
2022-04-07 2022-04-05 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,3019 49.728 114 1.994.721
2022-04-07 2022-04-04 4/A Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2585 122.342 276 1.944.993
2022-04-07 3/A Ma-Weaver Jacob ABIO Common Stock D 1.822.651
2022-04-04 2022-04-04 4 Funicular Fund, LP ABIO Common Stock P - Purchase D 2,2585 122.342 276 1.944.993
2022-04-04 3 Funicular Fund, LP ABIO Common Stock D 1.822.651
2021-12-16 2021-12-14 4 Ozeroff Christopher David ABIO Stock Option (right to buy) A - Award D 2,29 27.500 27.500
2021-12-16 2021-12-14 4 Keuer Thomas A ABIO Stock Option (right to buy) A - Award D 2,29 35.000 35.000
2021-12-16 2021-12-14 4 BRISTOW MICHAEL R ABIO Stock Option (right to buy) A - Award D 2,29 95.000 95.000
2021-12-16 2021-12-14 4 Dekker C. Jeffrey ABIO Stock Option (right to buy) A - Award D 2,29 17.700 17.700
2021-11-23 2021-11-22 4 Ozeroff Christopher David ABIO Common Stock P - Purchase D 2,2642 50.000 113 50.970
2021-05-13 2021-05-12 4 CONWAY ROBERT E ABIO Common Stock P - Purchase D 3,1947 10.000 32 50.000
2021-05-06 2021-05-05 4 CONWAY ROBERT E ABIO Common Stock P - Purchase D 3,2345 10.000 32 40.000
2021-01-13 2021-01-12 4 Hove Anders D ABIO Stock Option (right to buy) A - Award D 4,31 12.000 12.000
2021-01-13 2021-01-12 4 Grais Linda S ABIO Stock Option (right to buy) A - Award D 4,31 12.000 12.000
2021-01-13 2021-01-12 4 Woosley Raymond L. ABIO Stock Option (right to buy) A - Award D 4,31 12.000 12.000
2021-01-13 2021-01-12 4 MITCHELL DANIEL J ABIO Stock Option (right to buy) A - Award D 4,31 12.000 12.000
2021-01-13 2021-01-12 4 CONWAY ROBERT E ABIO Stock Option (right to buy) A - Award D 4,31 12.000 12.000
2020-12-23 2020-12-21 4 Keuer Thomas A ABIO Stock Option (right to buy) A - Award D 4,27 70.000 70.000
2020-12-23 2020-12-21 4 BRISTOW MICHAEL R ABIO Stock Option (right to buy) A - Award D 4,27 190.000 190.000
2020-12-23 2020-12-21 4 Selby Brian L. ABIO Stock Option (right to buy) A - Award D 4,27 55.000 55.000
2020-12-23 2020-12-21 4 Ozeroff Christopher David ABIO Stock Option (right to buy) A - Award D 4,27 55.000 55.000
2020-12-21 2020-12-18 4 CONWAY ROBERT E ABIO Common Stock P - Purchase D 4,1630 10.000 42 30.000
2020-09-25 2020-09-25 4 CONWAY ROBERT E ABIO Common Stock P - Purchase D 4,2799 5.000 21 20.000
2020-09-24 2020-09-22 4 CONWAY ROBERT E ABIO Common Stock P - Purchase D 4,6599 3.056 14 15.000
2020-09-21 2020-09-21 4 CONWAY ROBERT E ABIO Common Stock P - Purchase D 4,7660 10.000 48 11.944
2018-04-03 2018-04-02 4 Selby Brian L. ABIO Common Stock S - Sale D 0,4994 -1.114 -1 0
2018-04-03 2018-04-03 4 Keuer Thomas A ABIO Common Stock S - Sale D 0,5015 -482 -0 13.153
2018-03-05 2018-03-01 4 Hove Anders D ABIO Stock Option (right to buy) A - Award D 0,72 8.000 8.000
2018-03-05 2018-03-01 4 MITCHELL DANIEL J ABIO Stock Option (right to buy) A - Award D 0,72 8.000 8.000
2018-03-05 2018-03-01 4 Grais Linda S ABIO Stock Option (right to buy) A - Award D 0,72 8.000 8.000
2018-03-05 2018-03-01 4 Woosley Raymond L. ABIO Stock Option (right to buy) A - Award D 0,72 8.000 8.000
2018-03-05 2018-03-01 4 CONWAY ROBERT E ABIO Stock Option (right to buy) A - Award D 0,72 8.000 8.000
2018-03-01 2018-02-27 4 Selby Brian L. ABIO Common Stock S - Sale D 0,5300 -161 -0 1.114
2018-03-01 2018-02-28 4 Keuer Thomas A ABIO Common Stock S - Sale D 0,7180 -410 -0 13.635
2018-02-28 2018-02-27 4 VENROCK HEALTHCARE CAPITAL PARTNERS LP By Funds ABIO Common Stock S - Sale I 0,5300 -41.331 -22 0
2018-02-28 2018-02-26 4 VENROCK HEALTHCARE CAPITAL PARTNERS LP By Funds ABIO Common Stock S - Sale I 0,5500 -1.500.000 -825 41.331
2018-02-27 2018-02-26 4 BARRIS PETER J See Note 2 ABIO Common Stock S - Sale I 0,5008 -1.460.209 -731 0
2018-02-27 2018-02-26 4 BASKETT FOREST See Note 2 ABIO Common Stock S - Sale I 0,5008 -1.460.209 -731 0
2018-02-27 2018-02-26 4 Florence Anthony A. Jr. See Note 2 ABIO Common Stock S - Sale I 0,5008 -1.460.209 -731 0
2018-02-27 2018-02-26 4 Viswanathan Ravi See Note 2 ABIO Common Stock S - Sale I 0,5008 -1.460.209 -731 0
2018-02-27 2018-02-26 4 MAKOWER JOSHUA See Note 2 ABIO Common Stock S - Sale I 0,5008 -1.460.209 -731 0
2018-02-27 2018-02-26 4 MOTT DAVID M See Note 2 ABIO Common Stock S - Sale I 0,5008 -1.460.209 -731 0
2018-02-27 2018-02-26 4 Sakoda Jon See Note 2 ABIO Common Stock S - Sale I 0,5008 -1.460.209 -731 0
2018-02-27 2018-02-26 4 SANDELL SCOTT D See Note 2 ABIO Common Stock S - Sale I 0,5008 -1.460.209 -731 0
2018-02-27 2018-02-26 4 Sonsini Peter W. See Note 2 ABIO Common Stock S - Sale I 0,5008 -1.460.209 -731 0
2018-02-27 2018-02-26 4 Growth Equity Opportunities IV, LLC ABIO Common Stock S - Sale D 0,5008 -1.460.209 -731 0
2017-07-17 2017-07-14 4 CONWAY ROBERT E ABIO Common Stock P - Purchase D 2,4900 10.000 25 35.000
2017-05-03 2017-05-02 4 MITCHELL DANIEL J ABIO Common Stock P - Purchase D 2,7100 11.000 30 11.000
2017-04-05 2017-04-04 4 BRISTOW MICHAEL R ABIO Common Stock S - Sale D 2,4100 -720 -2 41.155
2017-04-05 2017-04-04 4 Keuer Thomas A ABIO Common Stock S - Sale D 2,4100 -390 -1 14.045
2017-04-05 2017-04-04 4 Ozeroff Christopher David ABIO Common Stock S - Sale D 2,4100 -418 -1 17.517
2017-04-05 2017-04-03 4 Selby Brian L. ABIO Common Stock S - Sale D 2,4600 -1.114 -3 1.275
2017-03-27 2017-03-24 4 CONWAY ROBERT E ABIO Common Stock P - Purchase D 2,5900 25.000 65 25.000
2017-03-01 2017-02-28 4 Ozeroff Christopher David ABIO Common Stock S - Sale D 2,6100 -465 -1 17.935
2017-03-01 2017-02-27 4 Ozeroff Christopher David ABIO Stock Option (right to buy) A - Award D 2,60 22.700 22.700
2017-03-01 2017-02-27 4 Selby Brian L. ABIO Stock Option (right to buy) A - Award D 2,60 24.100 24.100
2017-03-01 2017-02-27 4 Selby Brian L. ABIO Common Stock S - Sale D 2,5600 -161 -0 2.389
2017-03-01 2017-02-28 4 Keuer Thomas A ABIO Common Stock S - Sale D 2,6100 -465 -1 14.435
2017-03-01 2017-02-27 4 Keuer Thomas A ABIO Stock Option (right to buy) A - Award D 2,60 23.800 23.800
2017-03-01 2017-02-28 4 BRISTOW MICHAEL R ABIO Common Stock S - Sale D 2,6100 -763 -2 41.875
2017-03-01 2017-02-27 4 BRISTOW MICHAEL R ABIO Stock Option (right to buy) A - Award D 2,60 41.600 41.600
2017-02-21 3 Hove Anders D By Venrock Healthcare Capital Partners, L.P. ABIO Common Stock I 1.932.243
2017-02-21 3 Hove Anders D By VHCP Co-Investment Holdings, LLC ABIO Common Stock I 1.612.818
2017-02-21 3 Hove Anders D By VHCP Co-Investment Holdings II, LLC ABIO Common Stock I 1.852.603
2017-02-21 3 Hove Anders D By Venrock Healthcare Capital Partners, L.P. ABIO Common Stock I 1.932.243
2017-02-21 3 Hove Anders D By Venrock Healthcare Capital Partners II, L.P. ABIO Common Stock I 2.308.991
2017-02-21 3 Hove Anders D By Venrock Healthcare Capital Partners II, L.P. ABIO Common Stock I 2.308.991
2017-02-21 3 Hove Anders D By VHCP Co-Investment Holdings II, LLC ABIO Common Stock I 1.852.603
2017-02-21 3 Hove Anders D By VHCP Co-Investment Holdings, LLC ABIO Common Stock I 1.612.818
2017-02-21 2017-02-16 4 Grais Linda S ABIO Stock Option (right to buy) A - Award D 2,50 8.000 8.000
2017-02-21 2017-02-16 4 CONWAY ROBERT E ABIO Stock Option (right to buy) A - Award D 2,50 8.000 8.000
2017-02-21 2017-02-16 4 Ozeroff Christopher David ABIO Stock Option (right to buy) A - Award D 2,50 24.000 24.000
2017-02-21 2017-02-16 4 Selby Brian L. ABIO Stock Option (right to buy) A - Award D 2,50 23.000 23.000
2017-02-21 2017-02-16 4 MITCHELL DANIEL J ABIO Stock Option (right to buy) A - Award D 2,50 8.000 8.000
2017-02-21 2017-02-16 4 Keuer Thomas A ABIO Stock Option (right to buy) A - Award D 2,50 25.200 25.200
2017-02-21 2017-02-16 4 Hove Anders D ABIO Stock Option (right to buy) A - Award D 2,50 10.000 10.000
2017-02-21 2017-02-16 4 Woosley Raymond L. ABIO Stock Option (right to buy) A - Award D 2,50 8.000 8.000
2017-02-21 2017-02-16 4 BRISTOW MICHAEL R ABIO Stock Option (right to buy) A - Award D 2,50 42.000 42.000
2016-10-18 2016-10-18 4 Keuer Thomas A ABIO Common Stock S - Sale D 2,4510 -483 -1 14.900
2016-09-21 2016-09-19 4 Selby Brian L. ABIO Common Stock S - Sale D 2,9100 -476 -1 2.550
2016-09-21 2016-09-20 4 Ozeroff Christopher David ABIO Common Stock S - Sale D 2,8900 -1.185 -3 18.400
2016-09-21 2016-09-20 4 Keuer Thomas A ABIO Common Stock S - Sale D 2,8900 -714 -2 15.383
2016-09-21 2016-09-20 4 BRISTOW MICHAEL R ABIO Common Stock S - Sale D 2,8900 -1.972 -6 42.638
2016-06-13 2016-06-09 4 Selby Brian L. ABIO Stock Option (right to buy) A - Award D 3,30 32.100 32.100
2016-06-13 2016-06-09 4 Selby Brian L. ABIO Stock Option (right to buy) A - Award D 3,30 15.800 15.800
2016-06-13 2016-06-09 4 Ozeroff Christopher David ABIO Stock Option (right to buy) A - Award D 3,30 30.200 30.200
2016-06-13 2016-06-09 4 Ozeroff Christopher David ABIO Stock Option (right to buy) A - Award D 3,30 14.800 14.800
2016-06-13 2016-06-09 4 Keuer Thomas A ABIO Stock Option (right to buy) A - Award D 3,30 31.700 31.700
2016-06-13 2016-06-09 4 Keuer Thomas A ABIO Stock Option (right to buy) A - Award D 3,30 15.600 15.600
2016-06-13 2016-06-09 4 BRISTOW MICHAEL R ABIO Stock Option (right to buy) A - Award D 3,30 55.400 55.400
2016-06-13 2016-06-09 4 BRISTOW MICHAEL R ABIO Stock Option (right to buy) A - Award D 3,30 27.200 27.200
2016-04-06 2016-04-04 4 Selby Brian L. ABIO Common Stock S - Sale D 3,5200 -1.114 -4 3.026
2016-04-06 2016-04-05 4 Ozeroff Christopher David ABIO Common Stock S - Sale D 3,5200 -366 -1 19.585
2016-04-06 2016-04-05 4 Keuer Thomas A ABIO Common Stock S - Sale D 3,5200 -384 -1 16.097
2016-04-06 2016-04-05 4 BRISTOW MICHAEL R ABIO Common Stock S - Sale D 3,5200 -724 -3 44.610
2016-03-02 2016-02-29 4 Selby Brian L. ABIO Common Stock S - Sale D 3,4600 -160 -1 4.140
2016-03-02 2016-03-01 4 BRISTOW MICHAEL R ABIO Common Stock S - Sale D 3,5000 -752 -3 45.334
2016-03-02 2016-03-01 4 Ozeroff Christopher David ABIO Common Stock S - Sale D 3,5100 -458 -2 19.951
2016-03-02 2016-03-01 4 Keuer Thomas A ABIO Common Stock S - Sale D 3,5300 -457 -2 16.481
2016-02-16 2016-02-11 4 CONWAY ROBERT E ABIO Stock Option (right to buy) A - Award D 3,44 8.000 8.000
2016-02-16 2016-02-11 4 MITCHELL DANIEL J ABIO Stock Option (right to buy) A - Award D 3,44 8.000 8.000
2016-02-16 2016-02-11 4 Woosley Raymond L. ABIO Stock Option (right to buy) A - Award D 3,44 8.000 8.000
2016-02-16 2016-02-11 4 Grais Linda S ABIO Stock Option (right to buy) A - Award D 3,44 8.000 8.000
2015-10-19 2015-10-16 4 Keuer Thomas A ABIO Common Stock S - Sale D 5,1400 -496 -3 16.938
2015-09-21 2015-09-18 4 Selby Brian L. ABIO Common Stock S - Sale D 6,2300 -476 -3 4.300
2015-09-21 2015-09-18 4 Keuer Thomas A ABIO Common Stock S - Sale D 6,3300 -680 -4 17.407
2015-09-21 2015-09-18 4 BRISTOW MICHAEL R ABIO Common Stock S - Sale D 6,3300 -1.809 -11 46.086
2015-09-21 2015-09-18 4 Ozeroff Christopher David ABIO Common Stock S - Sale D 6,3200 -1.129 -7 20.409
2015-06-17 3 Sonsini Peter W. See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 Sonsini Peter W. See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 MAKOWER JOSHUA See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 MAKOWER JOSHUA See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 NEA 15 GP, LLC ABIO Common Stock D 20.442.930
2015-06-17 3 NEA 15 GP, LLC ABIO Common Stock D 20.442.930
2015-06-17 3 NEA 15 GP, LLC ABIO Common Stock D 20.442.930
2015-06-17 3 NEA 15 GP, LLC ABIO Common Stock D 20.442.930
2015-06-17 3 NEA 15 GP, LLC ABIO Common Stock D 20.442.930
2015-06-17 3 Weller Harry R See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 Weller Harry R See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 Viswanathan Ravi See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 Viswanathan Ravi See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 Florence Anthony A. Jr. See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 Florence Anthony A. Jr. See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 MOTT DAVID M See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 MOTT DAVID M See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 BASKETT FOREST See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 BASKETT FOREST See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 Sakoda Jon See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 Sakoda Jon See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 BARRIS PETER J See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 BARRIS PETER J See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 VHCP Management II, LLC By funds ABIO Common Stock I 21.578.648
2015-06-17 3 VHCP Management II, LLC By funds ABIO Common Stock I 21.578.648
2015-06-17 3 VHCP Management II, LLC By funds ABIO Common Stock I 21.578.648
2015-06-17 3 VHCP Management II, LLC By funds ABIO Common Stock I 21.578.648
2015-06-17 3 VHCP Management II, LLC By funds ABIO Common Stock I 21.578.648
2015-06-17 3 VHCP Management II, LLC By funds ABIO Common Stock I 21.578.648
2015-06-17 3 VHCP Management II, LLC By funds ABIO Common Stock I 21.578.648
2015-06-17 3 VHCP Management II, LLC By funds ABIO Common Stock I 21.578.648
2015-06-17 3 VHCP Management II, LLC By funds ABIO Common Stock I 21.578.648
2015-06-17 3 KOLLURI KRISHNA KITTU See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 KOLLURI KRISHNA KITTU See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 SANDELL SCOTT D See Note 1 ABIO Common Stock I 20.442.930
2015-06-17 3 SANDELL SCOTT D See Note 1 ABIO Common Stock I 20.442.930
2015-03-02 2015-03-02 4 Selby Brian L. ABIO Common Stock S - Sale D 0,7110 -1.125 -1 33.441
2015-03-02 2015-03-02 4 BRISTOW MICHAEL R ABIO Common Stock S - Sale D 0,7131 -5.446 -4 335.279
2015-02-17 2015-02-12 4 Woosley Raymond L. ABIO Stock Option (right to buy) A - Award D 0,67 8.000 8.000
2015-02-17 2015-02-12 4 Selby Brian L. ABIO Stock Option (right to buy) A - Award D 0,67 12.600 12.600
2015-02-17 2015-02-12 4 Selby Brian L. ABIO Common Stock A - Award D 23.400 34.566
2015-02-17 2015-02-12 4 CONWAY ROBERT E ABIO Stock Option (right to buy) A - Award D 0,67 8.000 8.000
2015-02-17 2015-02-12 4 BRISTOW MICHAEL R ABIO Stock Option (right to buy) A - Award D 0,67 25.900 25.900
2015-02-17 2015-02-12 4 BRISTOW MICHAEL R ABIO Common Stock A - Award D 48.100 340.725
2015-02-17 2015-02-12 4 Keuer Thomas A ABIO Stock Option (right to buy) A - Award D 0,67 13.650 13.650
2015-02-17 2015-02-12 4 Keuer Thomas A ABIO Common Stock A - Award D 25.350 126.626
2015-02-17 2015-02-12 4 Grais Linda S ABIO Stock Option (right to buy) A - Award D 0,67 8.000 8.000
2015-02-17 2015-02-12 4 Ozeroff Christopher David ABIO Stock Option (right to buy) A - Award D 0,67 12.950 12.950
2015-02-17 2015-02-12 4 Ozeroff Christopher David ABIO Common Stock A - Award D 24.050 150.787
2015-02-17 2015-02-12 4 MITCHELL DANIEL J ABIO Stock Option (right to buy) A - Award D 0,67 8.000 8.000
2015-01-16 2015-01-16 4 mccormack riley See above ABIO COMMON STOCK S - Sale I 0,7500 -100.000 -75 2.100.000
2015-01-16 2015-01-15 4 mccormack riley See above ABIO COMMON STOCK S - Sale I 0,7500 -125.000 -94 2.200.000
2015-01-16 2015-01-14 4 mccormack riley By Self as trustee for Riley McCormack 2011 Rev Trust ABIO COMMON STOCK S - Sale I 0,7900 -125.000 -99 2.325.000
2015-01-07 2015-01-07 4 mccormack riley See above ABIO COMMON STOCK S - Sale I 0,8700 -200.000 -174 2.450.000
2015-01-07 2015-01-06 4 mccormack riley See above ABIO COMMON STOCK S - Sale I 0,9200 -200.000 -184 2.650.000
2015-01-07 2015-01-05 4 mccormack riley By Self as trustee for Riley McCormack 2011 Rev Trust ABIO COMMON STOCK S - Sale I 0,9700 -150.000 -146 2.850.000
2014-12-30 3 Selby Brian L. ABIO Common Stock D 22.332
2014-12-30 3 Selby Brian L. ABIO Common Stock D 22.332
2014-12-30 3 Keuer Thomas A ABIO Common Stock D 202.552
2014-12-30 3 Keuer Thomas A ABIO Common Stock D 202.552
2014-09-19 2014-09-18 4 BRISTOW MICHAEL R ABIO Common Stock S - Sale D 1,3000 -13.853 -18 292.625
2014-09-19 2014-09-18 4 Wheeler Patrick M ABIO Common Stock S - Sale D 1,3100 -8.246 -11 101.510
2014-03-03 2014-02-27 4 BRISTOW MICHAEL R ABIO Stock Option (right to buy) A - Award D 1,95 51.500 51.500
2014-03-03 2014-02-27 4 BRISTOW MICHAEL R ABIO Common Stock A - Award D 1,9500 56.700 111 306.478
2014-03-03 2014-02-27 4 Ozeroff Christopher David ABIO Stock Option (right to buy) A - Award D 1,95 10.500 10.500
2014-03-03 2014-02-27 4 Ozeroff Christopher David ABIO Common Stock A - Award D 1,9500 34.200 67 126.737
2014-03-03 2014-02-27 4 Wheeler Patrick M ABIO Stock Option (right to buy) A - Award D 1,95 20.500 20.500
2014-03-03 2014-02-27 4 Wheeler Patrick M ABIO Common Stock A - Award D 1,9500 34.200 67 109.756
2014-02-13 3 MITCHELL DANIEL J ABIO Common Stock D 0
2014-02-13 2014-02-11 4 Grais Linda S ABIO Stock Option (right to buy) A - Award D 1,80 8.000 8.000
2014-02-13 2014-02-11 4 CONWAY ROBERT E ABIO Stock Option (right to buy) A - Award D 1,80 8.000 8.000
2014-02-13 2014-02-11 4 Woosley Raymond L. ABIO Stock Option (right to buy) A - Award D 1,80 8.000 8.000
2014-02-04 2014-02-04 4 mccormack riley By Self as Trustee for Riley McCormack 2011 Rev Trust ABIO Warrant to purchase common stock P - Purchase I 2,12 250.000 250.000
2014-02-04 2014-02-04 4 mccormack riley By Self as Trustee for Riley McCormack 2011 Rev Trust ABIO COMMON STOCK P - Purchase I 1,7000 1.000.000 1.700 3.000.000
2013-10-07 3 mccormack riley ABIO Common Stock D 2.000.000
2013-09-19 2013-09-17 4 Ozeroff Christopher David ABIO Stock Option (right to buy) A - Award D 1,38 42.642 42.642
2013-09-19 2013-09-17 4 Ozeroff Christopher David ABIO Common Stock A - Award D 1,3800 75.000 103 92.537
2013-09-19 2013-09-17 4 CONWAY ROBERT E ABIO Stock Option (right to buy) A - Award D 1,38 2.608 2.608
2013-09-19 2013-09-17 4 CONWAY ROBERT E ABIO Stock Option (right to buy) A - Award D 1,38 14.750 14.750
2013-09-19 2013-09-17 4 Grais Linda S ABIO Stock Option (right to buy) A - Award D 1,38 7.417 7.417
2013-09-19 2013-09-17 4 Grais Linda S ABIO Stock Option (right to buy) A - Award D 1,38 16.000 16.000
2013-09-19 2013-09-17 4 BRISTOW MICHAEL R ABIO Stock Option (right to buy) A - Award D 1,38 282.825 282.825
2013-09-19 2013-09-17 4 BRISTOW MICHAEL R ABIO Common Stock A - Award D 1,3800 125.000 172 249.778
2013-09-19 2013-09-17 4 Woosley Raymond L. ABIO Stock Option (right to buy) A - Award D 1,38 3.463 3.463
2013-09-19 2013-09-17 4 Woosley Raymond L. ABIO Stock Option (right to buy) A - Award D 1,38 14.750 14.750
2013-09-19 2013-09-17 4 Wheeler Patrick M ABIO Stock Option (right to buy) A - Award D 1,38 81.856 81.856
2013-09-19 2013-09-17 4 Wheeler Patrick M ABIO Common Stock A - Award D 1,3800 75.000 103 75.556
2013-09-19 2013-09-17 4 ZABRISKIE JOHN L ABIO Stock Option (right to buy) A - Award D 1,38 7.417 7.417
2013-09-19 2013-09-17 4 ZABRISKIE JOHN L ABIO Stock Option (right to buy) A - Award D 1,38 16.000 16.000
2013-09-04 3 CONWAY ROBERT E ABIO Common Stock D 0
2013-07-30 3 Woosley Raymond L. ABIO Common Stock D 0
2013-07-30 2013-07-26 4 ZABRISKIE JOHN L ABIO Option to Purchase Common Stock (right to buy) A - Award D 1,40 583 583
2013-07-30 2013-07-26 4 Grais Linda S ABIO Option to Purchase Common Stock (right to buy) A - Award D 1,40 583 583
2013-06-14 2013-06-12 4 BRISTOW MICHAEL R ABIO Series A Convertible Preferred Stock C - Conversion D 160,0000 -781 -125 0
2013-06-14 2012-06-12 4 BRISTOW MICHAEL R ABIO Common Stock C - Conversion D 78.100 124.778
2013-06-06 2013-06-04 4 BRISTOW MICHAEL R ABIO Common Stock Warrants (right to buy) A - Award D 1,60 39.050 39.050
2013-06-06 2013-06-04 4 BRISTOW MICHAEL R ABIO Series A Convertible Preferred Stock A - Award D 160,0000 781 125 781
2013-01-28 2013-01-25 4 BRISTOW MICHAEL R By NFS Custodian for Michael Bristow's IRA ABIO Common stock warrants (right to buy) P - Purchase I 0,38 748.503 748.503
2013-01-28 2013-01-25 4 BRISTOW MICHAEL R By NFS Custodian for Michael Bristow's IRA ABIO Common Stock P - Purchase I 0,4676 1.069.290 500 1.069.290
2012-12-20 2012-12-18 4 BRISTOW MICHAEL R By Investocor Trust, as sole trustee ABIO Common stock warrants (right to buy) A - Award I 0,39 387.837 387.837
2012-12-20 2012-12-18 4 BRISTOW MICHAEL R By Investocor Trust, as sole trustee ABIO Common Stock A - Award I 0,4835 517.116 250 834.495
2012-11-02 3 Atlas Venture Associates VII, L.P. ABIO Common Stock D 1.579.542
2012-10-24 2012-10-22 4 FORMELA JEAN FRANCOIS ABIO Common Stock Warrants (right to buy) A - Award I 0,30 238.034 313.483
2012-10-24 2012-10-22 4 FORMELA JEAN FRANCOIS See Foonote ABIO Common Stock A - Award I 0,3939 317.379 125 1.579.542
2012-10-24 2012-10-22 4 BRISTOW MICHAEL R By Investocor Trust, as sole trustee ABIO Common Stock Warrants (right to buy) A - Award I 0,30 238.034 238.024
2012-10-24 2012-10-22 4 BRISTOW MICHAEL R By Investocor Trust, as sole trustee ABIO Common Stock A - Award I 0,3939 317.379 125 317.379
2012-10-24 2012-10-22 4 Ozeroff Christopher David ABIO Common Stock Warrant (right to buy) A - Award D 0,30 47.606 47.606
2012-10-24 2012-10-22 4 Ozeroff Christopher David ABIO Common Stock A - Award D 0,3939 63.475 25 105.233
2012-10-24 2012-10-22 4 ZABRISKIE JOHN L ABIO Common Stock Warrants (right to buy) A - Award I 0,30 95.213 95.213
2012-10-24 2012-10-22 4 ZABRISKIE JOHN L ABIO Common Stock A - Award I 0,3939 126.951 50 156.131
2012-02-14 2012-02-10 4 FORMELA JEAN FRANCOIS See footnote (1) ABIO Option to Purchase Common Stock A - Award I 1,00 3.500 3.500
2012-02-14 2012-02-10 4 FORMELA JEAN FRANCOIS See footnote (1) ABIO Option to Purchase Common Stock A - Award I 1,00 3.500 3.500
2012-02-14 2012-02-10 4 ZABRISKIE JOHN L ABIO Option to Purchase Common Stock A - Award D 1,00 3.500 3.500
2012-02-14 2012-02-10 4 ZABRISKIE JOHN L ABIO Option to Purchase Common Stock A - Award D 1,00 3.500 3.500
2012-02-14 2012-02-10 4 SOBEL BURTON E ABIO Option to Purchase Common Stock A - Award D 1,00 3.500 3.500
2012-02-14 2012-02-10 4 SOBEL BURTON E ABIO Option to Purchase Common Stock A - Award D 1,00 3.500 3.500
2012-02-14 2012-02-10 4 Grais Linda S ABIO Option to Purchase Common Stock A - Award D 1,00 3.500 3.500
2012-02-14 2012-02-10 4 Grais Linda S ABIO Option to Purchase Common Stock A - Award D 1,00 3.500 3.500
2012-02-14 2012-02-10 4 BREWER RICHARD B ABIO Option to Purchase Common Stock A - Award D 1,00 3.500 3.500
2012-02-14 2012-02-10 4 BREWER RICHARD B ABIO Option to Purchase Common Stock A - Award D 1,00 3.500 3.500
2009-12-15 3 Wheeler Patrick M ABIO Common Stock D 3.338
2009-04-08 2009-04-06 4 BOULDER VENTURES IV ANNEX LP By BV Partners IV, LLC ABIO Common Stock J - Other I 31 549
2009-04-08 2009-04-06 4 BOULDER VENTURES IV ANNEX LP By BV Partners IV, LLC ABIO Common Stock J - Other I 518 518
2009-04-08 2009-04-06 4 BOULDER VENTURES IV ANNEX LP By Boulder Ventures IV, L.P. ABIO Common Stock J - Other I -3.292 44.715
2009-04-08 2009-04-06 4 BOULDER VENTURES IV ANNEX LP ABIO Common Stock J - Other D -49.708 675.403
2009-03-03 3 FALBERG KATHRYN E ABIO Common Stock D 21.000
2009-03-03 2009-02-27 4 PENDERGAST MARY K ABIO Option to Purchase Common Stock A - Award D 5,29 7.500 7.500
2009-03-03 2009-02-27 4 SOBEL BURTON E ABIO Option to Purchase Common Stock A - Award D 5,29 7.500 7.500
2009-03-03 2009-02-27 4 LOVE TED W ABIO Option to Purchase Common Stock A - Award D 5,29 7.500 7.500
2009-02-05 3 BREWER RICHARD B ABIO Common Stock D 83.490
2009-02-05 3 BRISTOW MICHAEL R ABIO Common Stock D 272.677
2009-02-05 3 FORMELA JEAN FRANCOIS ABIO Common Stock I 1.402.163
2009-02-05 3 FREYTAG J WILLIAM ABIO Common Stock D 0
2009-02-05 3 Lowe David George ABIO Common Stock I 877.583
2009-02-05 3 Grais Linda S ABIO Common Stock I 702.698
2009-02-05 3 Skyline Venture Partners Qualified Purchaser Fund IV L P ABIO Common Stock D 877.583
2009-02-05 3 Ozeroff Christopher David ABIO Common Stock D 79.388
2009-02-05 3 St Laurent Randall ABIO None D 0
2009-02-05 3 Roshko Peter By Boulder Ventures IV, L.P. ABIO Common Stock I 48.007
2009-02-05 3 Roshko Peter ABIO Common Stock D 725.111
2009-02-05 3 ZABRISKIE JOHN L ABIO Common Stock I 29.180
2004-09-02 2004-07-30 4 CREDIT SUISSE AG/ NUVO Warrants C - Conversion I 4,98 -698 0
2004-09-02 2004-07-30 4 CREDIT SUISSE AG/ NUVO Warrants C - Conversion I 4,98 -12.562 0
2004-09-02 2004-07-30 4 CREDIT SUISSE AG/ NUVO Warrants C - Conversion I 4,98 -209.364 0
2004-09-02 2004-07-30 4 CREDIT SUISSE AG/ NUVO Warrants C - Conversion I 4,98 -18.218 0
2004-09-02 2004-07-30 4 CREDIT SUISSE AG/ See footnote(s) NUVO Common Stock C - Conversion I 4,9800 698 3 7.230
2004-09-02 2004-07-30 4 CREDIT SUISSE AG/ See footnote(s) NUVO Common Stock C - Conversion I 4,9800 12.562 63 130.088
2004-09-02 2004-07-30 4 CREDIT SUISSE AG/ See footnote(s) NUVO Common Stock C - Conversion I 4,9800 209.364 1.043 1.215.554
2004-09-02 2004-07-30 4 CREDIT SUISSE AG/ See footnote(s) NUVO Common Stock C - Conversion I 4,9800 18.218 91 188.667
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista